Mitochondrial dysfunction is believed to participate in Huntington's disease (HD) 
Huntington's disease (HD) is a hereditary neurodegenerative disorder caused by a mutation in the gene encoding huntingtin (Htt). Mutant Htt contains an abnormal polyglutamine (polyQ) expansion, responsible for deleterious effects (HDCRG 1993) . Despite similar expression levels throughout the brain, mutant Htt selectively targets striatal neurons, with the cerebral cortex being affected later in the disease (Vonsattel and DiFiglia 1998) . Mitochondrial dysfunction likely contributes to HD pathogenesis (Beal 2005) , and may underlie the selective neuronal degeneration.
Mitochondrial dysfunction in HD was proposed to stem from a direct interaction with mutant Htt (Panov et al. 2002) , decreasing mitochondrial Ca 2+ -loading capacity and thus rendering neurons more vulnerable to Ca 2+ -mediated excitotoxicity. However, studies of mitochondrial Ca 2+ -loading capacity in HD have provided conflicting results. Decreased Ca 2+ -loading capacity was observed in mitochondria isolated from immortalized lymphocytes (lymphoblasts) of HD patients, brains of YAC72 HD mice (Panov et al. 2002) , and livers of knock-in HD mice (Choo et al. 2004) . In contrast, increased Ca 2+ -loading capacity was observed in isolated brain mitochondria from R6/2 and knock-in HD mice (Brustovetsky et al. 2005) . Hence, changes in the Ca 2+ -loading capacity of HD mitochondria remain controversial and thus require further evaluation. Moreover, as most functional studies have been performed with mitochondria isolated from their cellular context, how HD affects in situ mitochondrial function, namely in the vulnerable striatal neurons, remains largely unknown.
Mitochondria can only accumulate Ca 2+ until the onset of permeability transition (PT). Because experimental conditions strongly influence PT onset (Chalmers and Nicholls 2003) and may account for some of the discrepancies in the literature concerning the Ca 2+ -loading capacity of HD mitochondria, in the present work, we adopt strategies to study mitochondrial Ca 2+ -loading capacity independently from other potential bioenergetic differences. Thus, Ca 2+ was slowly infused (Zoccarato and Nicholls 1982) into a dilute mitochondrial suspension supplemented with adenine nucleotides. A previous study with rat brain mitochondria (Chalmers and Nicholls 2003) showed that this provided a highly reproducible measure of Ca 2+ -loading capacity by minimizing bioenergetic demands on the mitochondria that result in depolarization or NAD(P)H oxidation.
In the present study, we assess the Ca
2+
-loading capacities of forebrain mitochondria isolated from three different transgenic HD mouse models. We find an increased Ca 2+ -loading capacity in mitochondria from R6/2 and YAC128 mice, but not in those from homozygous or heterozygous Hdh150 knock-in mice. Having failed to detect Ca 2+ -handling abnormalities with isolated mitochondria from knock-in mice, we tested for selective mitochondrial dysfunction in intact striatal neurons that might have been concealed in the mixture of neuronal and glial mitochondria isolated from the forebrain.
In this study, we present the first determination of in situ mitochondria respiratory function in intact HD striatal neurons, using a previously described technique (Jekabsons and Nicholls 2004 ) that avoids many of the artifacts inherent to isolated mitochondrial preparations. We find that in situ mitochondria show surprisingly high respiratory control, and that moderate expression of mutant Htt (in Hdh150 knock-in heterozygous) does not significantly impair mitochondrial respiration, at least in resting young neurons. However, when we challenge in situ mitochondria with high Ca 2+ , by transiently activating NMDA receptors, we find that Hdh150 striatal neurons fail to reestablish Ca 2+ homeostasis in higher proportion, when compared with neurons from wild-type littermates. These results stress the importance of assessing HD mitochondria function in situ, i.e., in the appropriate cellular context. Calcium Green 5 N (CaG5 N) , tetramethylrhodamine methyl ester (TMRM + ) and Fluo-5F AM were from Molecular Probes (Eugene, OR, USA). Culture media and supplements were purchased from Invitrogen (Carlsbad, CA, USA). NMDA, (5R,10S)-(+)-5-methyl-10,11-dihydro [a,d] cyclohepten -5,10-imine hydrogen maleate, myxothiazol, oligomycin, rotenone, carbonylcyanide-p-(trifluoromethoxyphenyl) hydrazone (FCCP) and other reagents were from Sigma (St. Louis, MO, USA).
Materials and methods

Materials
Mouse forebrain mitochondria
Transgenic mice All procedures involving animals were performed in accordance with the Institutional Animal Care and Use Committee guidelines. Twelve-to-thirteen-week-old R6/2 (Mangiarini et al. 1996) , 52-55 week-old YAC128 (Slow et al. 2003) and 15-17 week-old Hdh150 knock-in HD transgenic mice (Lin et al. 2001 ) and respective wild-type littermates (backgrounds: B5CBAF1/J, FVB/ N and C57BL/6 J, respectively) were used in this study. R6/2 mice express a short N-terminal fragment of human Htt with 150 polyQ, in addition to wild-type mouse Htt (Mangiarini et al. 1996) , presenting rapid disease onset and early death when compared with HD mice expressing full-length Htt (Hickey and Chesselet 2003 ) (Lin et al. 2001) . The wild-type littermates of these knock-in mice are hereafter designated by Hdh +/+ .
Isolation
Mitochondria were isolated from mouse forebrain (brain minus cerebellum). The cerebellum was excluded as it is usually not involved in HD pathology (Vonsattel and DiFiglia 1998) . Similar to previous studies about mitochondrial Ca 2+ -loading capacity in HD transgenic mice (Panov et al. 2002; Brustovetsky et al. 2005) , percoll gradient centrifugation (Sims 1990 ) was used to prepare non-synaptosomal mitochondria (see Appendix S1 for details). (Zoccarato and Nicholls 1982) . CaG5 N was excited at 506 nm and emission collected at 532 nm. Changes in Dw m were followed qualitatively by the fluorescence quenching of TMRM + (549 nm excitation, 575 nm emission).
Mitochondrial
Cultured striatal neurons
Cell culture Primary striatal cultures were generated from the offspring of crosses between two heterozygous Hdh150 mice or between a heterozygous male and a wild-type female from the same genetic background (C57BL/6 J). Brains from E16-17 embryos were rapidly removed into ice-cold Hank's balanced salt solution, while tails and livers were collected for PCR genotyping (Fig. S1a) . The genotyping procedure, requiring DNA purification, was not sufficiently fast to allow for brain pooling. Therefore, the entire culture procedure was performed in parallel for individual brains, resulting in 'single-embryo striatal cultures' plated blindly to genotype. Briefly, striata were dissected, minced with a scalpel and dissociated with 0.25% trypsin-EDTA. After enzyme inhibition with 10% heatinactivated fetal bovine serum in Neurobasal medium, cells were plated onto 8-well chambered coverglasses (LabTek, Naperville, IL, USA) at a density of 2.5 · 10 5 cells per well, or onto 22 · 40-mm glass coverslips at a density of 1 · 10 6 cells per coverslip. The glass was previously coated with 33 lg/mL polyethyleneimine. Cultures were maintained in Neurobasal medium supplemented with 1% glutamax, 2% B27, 1% fetal bovine serum, 100 U/mL penicillin and 0.1 lg/mL streptomycin. Two days after plating, 10 lmol/L cytosine arabinoside was added to inhibit growth of glial cells. After 4 days in vitro (DIV), cells were fed by replacing half the culture media. At 9 DIV glucose was added to a final concentration of 15 mmol/L using a 1.6 mol/L stock solution. Cultures were maintained at 37°C in a 95/5% air/CO 2 incubator and used for experiments at 10-13 DIV. Normal and mutant Htt expression in neuronal cultures was confirmed by western blotting (Fig. S1b ).
Cell respirometer
Measurements of oxygen uptake by intact coverslip-attached neurons using a 'cell respirometer' were previously described in detail (Jekabsons and Nicholls 2004) . Briefly, 22 · 40-mm coverslips with attached neurons were mounted in a perfusion chamber (RC-30; Warner Instruments, Hamden, CT, USA) coupled to two miniature polarographic Clark-type oxygen electrodes (Microelectrodes Inc., Bedford, NH, USA) monitoring the oxygen tension of the solution entering and exiting the chamber. Perfusion media was composed by (in mmol/L): 120 NaCl, 3.5 KCl, 0.4 KH 2 PO 4 , 1.3 CaCl 2 , 5 NaHCO 3 , 1.2 Na 2 SO 4 , 20 TES, 15 glucose, 10 pyruvate, 0.4% fatty acid free BSA, pH 7.4 at 37°C.
Functional confocal microscopy
Single-cell imaging of neurons, plated in 8-well Lab-Tek chambers, was performed in a Zeiss Pascal confocal Axiovert 100 M inverted microscope (Thornwood, NY, USA) using a 20 · air objective (at 0.7 zoom) and argon (488 nm) and helium-neon (543 nm Experiments were performed in this buffer at 37°C. Cells were excited at 488 nm for Fluo-5F (emission 505-530) and at 543 nm for TMRM + (emission > 560 nm). Individual cell somata were identified as regions of interest for the determination of fluorescence time-courses. NMDA receptor activation was achieved with 100 lmol/L NMDA/10 lmol/L glycine in the absence of Mg 2+ .
After 10 min, MK801 (5 lmol/L) was added to block receptor activation and allow for neuronal recovery.
Results
Mitochondrial Ca 2+ -loading capacity from different Huntington's disease mouse models during steady Ca
2+ -infusion
In this study, we compare the Ca 2+ -loading capacity of forebrain mitochondria isolated from different transgenic HD mice (R6/2, YAC128 and Hdh150 knock-in) and respective wild-type littermates. Mitochondrial Ca 2+ -loading capacity was estimated by a continuous Ca 2+ -infusion procedure (Zoccarato and Nicholls 1982) , avoiding the bioenergetic demands that result from Ca 2+ -bolus addition. Also, a diluted mitochondrial suspension was used (0.1 mg/mL) to avoid premature propagation of the permeability transition (premature PT) by a sub-population of susceptible mitochondria releasing sufficient Ca 2+ to trigger a 'chain-reaction' overload and PT in adjacent mitochondria, which may cause to underestimate the Ca 2+ -loading capacity of the overall population (Chalmers and Nicholls 2003 Addition of mitochondria to the incubation medium reduces [Ca 2+ ] e , as the residual cation in the media is taken up by the organelle, and decreases TMRM + fluorescence because of probe uptake and quenching in the matrix (Fig. 1a) . The onset of Ca 2+ -infusion (at 21 nmol/mg/min) increases [Ca 2+ ] e into a plateau, as the Ca 2+ accumulating activity of the mitochondrial uniporter gets in balance with both the infusion rate and the mitochondrial Ca 2+ -efflux pathway (Zoccarato and Nicholls 1982; Chalmers and Nicholls 2003 (and thus TMRM + dequenching, which increases its fluorescence). While Ca 2+ release is buffered to a specific setpoint by uniporter reuptake into the polarized mitochondria, the reuptake of TMRM + is governed by Nernst equilibrium and hence does not match what is released by the fraction of the mitochondria undergoing early PT because of the decrease in aggregate matrix volume (Chalmers and Nicholls 2003) . Thus, the assessment of mitochondrial Ca 2+ -loading capacity by monitoring the rise in [Ca 2+ ] e (Fig. 1a) is a better estimate of the overall mitochondrial population, than the monitoring of the distribution of Dw m sensitive probes such as TMRM + . A comparison of mitochondrial Ca 2+ -loading capacity for different HD mouse models is shown in Fig. 1b . Irrespective of the genetic background, mitochondria from wild-type mice exhibit a similar Ca 2+ -loading capacity (316 ± 15, 323 ± 37 and 305 ± 11 nmol/mg for the wild-type littermates of R6/2, YAC128 and Hdh150 knock-in mice, respectively (Fig. 1b -white bars) . Interestingly, mitochondria from both R6/2 and YAC128 mice present an increased Ca 2+ -loading capacity (386 ± 27 and 454 ± 10 nmol/mg for R6/2 and YAC128, respectively; *p < 0.05 vs. wild-type littermates). This effect is not apparent in Hdh150 knock-in animals where Ca 2+ -loading capacities were similar to wildtype littermates (294 ± 11 and 284 ± 21 nmol/mg, for heterozygous and homozygous animals, respectively). It should be noted that R6/2 mice at 12 weeks, as used in the present study, are resistant to quinolinic acid injection in the striatum (Hansson et al. 2001) , and both cortical and striatal mitochondria have increased glutathione levels (Choo et al. 2005) , compatible with the observed increase in mitochondrial Ca 2+ -loading capacity, in agreement with previous findings (Brustovetsky et al. 2005) . Also, YAC128 mice at the age used in the present study (12 months) present cortical and striatal atrophy associated with striatal neuronal loss (Slow et al. 2003) , and cognitive dysfunction (Van Raamsdonk et al. 2005) , supportive of ongoing HD neuropathology and hence compatible with our observation of abnormal mitochondrial Ca 2+ -handling. In contrast, knock-in HD mice usually have less widespread pathology than other genetic HD models (Hickey and Chesselet 2003 (Lin et al. 2001) , suggesting ongoing HD neuropathology at the age used in the present study (15-17 weeks). To the best of our knowledge, there are no previous studies with brain mitochondria from Hdh150 knock-in mice. However, abnormalities in striatal but not cortical mitochondria Ca 2+ -handling have been reported at 12 weeks for other knock-in mice with shorter Htt polyQ tracts (Brustovetsky et al. 2005 ). Hence, it is possible that the mixed neuronal glial population of the forebrain might have concealed a dysfunction selective for striatal neurons in Hdh150 knock-in mice. Therefore, and having in mind the faithful reproduction of the HD genotype in knock-in mice (Hickey and Chesselet 2003) , we studied in situ mitochondrial function in cultured striatal neurons from these mice.
In situ mitochondrial respiration in striatal neurons from Hdh 150/+ knock-in mice and wild-type littermates Using a cell respirometer (Jekabsons and Nicholls 2004) , we monitored in situ mitochondrial respiration of intact coverslip-attached striatal neurons from heterozygous Hdh150 knock-in mice (Hdh 150/+ ) and wild-type (Hdh +/+ ) littermates (Fig. 2) . In each experiment, we compared an Hdh +/+ with an Hdh 150/+ from the same litter. We tested three pairs of littermates (n = 3 experiments), each pair deriving from a different litter. Four respiratory rates were measured: basal (V basal ), maximal uncontrolled respiration in the presence of 9 lmol/L FCCP (V FCCP ), oligomycin (0.2 lg/mL)-insensitive (V oligo ), and residual non-mitochondrial respiration (V rot/myx ) in the presence of 1 lmol/L rotenone plus 2 lmol/L mixothiazol (oligomycin maintained after V oligo assessment).
The in situ mitochondrial respiration accounts for 91% of basal respiration [(V basal ) V rot/myx )/V basal = 90.7 ± 0.4% Susceptibility to NMDA-receptor activation of striatal neurons from Hdh150 knock-in mice Having observed no major effect of mutant Htt expression on mitochondrial respiration of resting Hdh 150/+ striatal neurons, we asked whether challenging of in situ mitochondria with energy-demanding stimuli, such as high [Ca 2+ ] i , might reveal differences unapparent under resting conditions. To address this question, we assessed the ability of striatal neurons to reestablish neuronal homeostasis following transient NMDAreceptor (NMDAR) activation (Fig. 3) . NMDAR activation leads to massive Ca 2+ -entry, threatening neuronal survival. Mitochondria play an important role in the maintenance of neuronal homeostasis, both by taking up Ca 2+ and synthesizing ATP required for energy-dependent homeostatic mechanisms. To accentuate this mitochondrial role, we performed experiments in media with pyruvate (10 mmol/L) instead of glucose. Under these conditions, neurons depend on ATP derived solely from oxidative phosphorylation, thus accentuating the bioenergetic consequences of mitochondrial dysfunction. Indeed, if mitochondrial Ca 2+ -uptake and ATP synthesis are prevented (treatment with 1 lmol/L rotenone plus 2 lg/mL oligomycin), striatal neurons fail to recover from NMDAR activation (not shown).
Changes in neuronal homeostasis were estimated by the dynamic monitoring of changes in [Ca 2+ ] i and Dw m by fluorescence microscopy with Fluo-5F and TMRM + . A 10 min challenge with 100 lmol/L NMDA / 10 lmol/L glycine, followed by receptor blockade with 5 lmol/L (5R,10S)-(+)-5-methyl-10,11-dihydro [A,D] cyclohepten -5,10-imine hydrogen maleate, permitted the distinction between striatal neurons able to re-establish cellular homeostasis ('recovery') and those that underwent intracellular Ca 2+ deregulation associated with Dw m collapse ('deregulation'), a condition that is well correlated with necrotic cell death (Nicholls and Budd 2000; Fig. 3a) . For each experiment, we analyzed the responses from 250 individual neurons and calculated the percentage unable to recover from NMDAR activation, i.e., exhibiting 'deregulation' (Fig. 3b) . Expression of mutant huntingtin increases the proportion of striatal neurons unable to recover from NMDAR activation. 11.9 ± 0.5% of wild-type (Hdh +/+ , 1250 neurons analyzed) versus 21.0 ± 2.8% of heterozygous Hdh150 knock-in striatal neurons (Hdh 150/+ , 1500 neurons analyzed) exhibit 'deregulation' following NMDAR activation (five vs. six embryos from three different litters; *p < 0.05 unpaired t-test with Welch's correction for unequal variances; Fig. 3b) .
Obtaining homozygous Hdh150 embryos (Hdh 150/150 ) with wild-type littermates was a difficult task as it required the mating of two heterozygous animals and the killing of pregnant transgenic females. In addition, not all heterozygous · heterozygous crosses yielded homozygous progeny. We managed to collect functional data from two separately assayed sister cultures from the same Hdh 150/150 embryo and observed a percentage of 44.8 ± 4.4% of striatal neurons (500 neurons analyzed) exhibiting 'deregulation' following NMDAR activation. It is noteworthy that this percentage is higher than in any of the individual experiments performed with neurons from Hdh +/+ and Hdh 150/+ embryos, and that the entire neuronal culture procedure and plating was blinded to genotype.
Discussion
Here, we have assessed the Ca 2+ -loading capacity of isolated forebrain mitochondria from three different transgenic HD mice. Using experimental conditions that prevent premature PT propagation by mitochondrial sub-populations, i.e., the use of low mitochondrial concentrations and the inclusion of adenine nucleotides in the incubation, we find that wild-type mitochondria from three different genetic backgrounds present similar Ca 2+ -loading capacities. In contrast, Ca 2+ -loading capacity is increased in forebrain mitochondria isolated from R6/2 and YAC128 HD mice, but not in those from Hdh150 knock-in mice with less severe pathology. When focusing on neurons selectively targeted by HD, we find that moderate mutant Htt expression, in Hdh 150/+ striatal neurons, does not significantly impair in situ mitochondrial respiration. However, when in situ mitochondria are challenged with high Ca 2+ by transient NMDAR activation, mutant Htt expression is associated with a higher proportion of striatal neurons failing to re-establish Ca 2+ homeostasis. We conclude that in order to understand more deeply how mitochondrial function is affected in HD, studies need to be conducted not only with isolated mitochondria but also with in situ mitochondria.
Functional assays with HD mitochondria have mostly been performed with the isolated organelle (Panov et al. 2002; Choo et al. 2004; Brustovetsky et al. 2005) . As isolation removes mitochondria from the cytoplasm, extrapolations to in vivo HD are limited. Moreover, as non-synaptosomal brain preparations (Panov et al. 2002; Brustovetsky et al. 2005) are inevitably contaminated with glial mitochondria and are depleted in synaptic mitochondria, both neuronal-selective and synaptic dysfunction will be obscured. Hence, despite considerable progress, several fundamental questions raised by isolated mitochondria studies remain unsettled or yet to be addressed by studying in situ HD mitochondria.
Considering the conflicting results previously obtained with isolated HD mitochondria (Panov et al. 2002; Choo et al. 2004; Brustovetsky et al. 2005) , the effects of mutant Htt on mitochondrial Ca 2+ -handling are still debatable. Brustovetsky et al. (2005) reported an age-dependent increase in the Ca 2+ -loading capacity of striatal but not of cortical mitochondria isolated from HD mice. In no instance did Brustovetsky et al. (2005) observe a decreased Ca 2+ -loading capacity for HD mitochondria, in contrast to earlier reports for HD brain mitochondria and for liver and lymphoblast HD mitochondria (Panov et al. 2002; Choo et al. 2004) . The approximately 3-6-fold variation in mitochondrial concentration between these studies is noteworthy [0.16 mg/mL (Brustovetsky et al. 2005) vs. 0.5 mg/ mL (Panov et al. 2002) and 1 mg/mL (Choo et al. 2004) ], because high concentrations increase the possibility that a minor subset of susceptible mitochondria might trigger early PT in the overall population, underestimating the Ca 2+ -loading capacity of the major population. Our present data, using a slow Ca 2+ -infusion into a diluted (0.1 mg/mL) mitochondrial suspension to minimize this premature PT propagation, are consistent with an increased Ca 2+ -loading capacity in the overall HD mitochondria population. Hence, at least for HD brain mitochondria, the opposing results could be reconciled assuming that the majority of the population does acquire enhanced resistance to Ca 2+ loads (Brustovetsky et al. 2005) , but that they include a small yet vulnerable fraction that can trigger premature PT in the population if high mitochondrial concentrations are used (Panov et al. 2002) . While a deleterious interaction with mutant Htt may explain why some HD mitochondria are more vulnerable to Ca 2+ (Panov et al. 2002 (Panov et al. , 2003 , possible reasons behind the 'population resistance' are less straightforward. Increased mitochondrial resistance may result from adaptive responses to a stressful environment, as previously proposed (Brustovetsky et al. 2005 ).
An apparent increase in brain mitochondria resistance to Ca 2+ over-load could derive from the fact that isolated brain mitochondria are an inevitable mixture of neuronal and glial mitochondria and that these mitochondria differ (Bambrick et al. 2004; Kristian et al. 2005) . As neuronal loss in HD is accompanied by glial proliferation (Myers et al. 1991) , a decreased neuron/glia ratio could account for increased resistance of the mitochondrial population without adaptive changes in individual mitochondria. Indeed, neuronal loss and/or gliosis have been described for several HD mouse models (Reddy et al. 1998; Lin et al. 2001; Slow et al. 2003; Yu et al. 2003) , but even non-lethal neuronal atrophy by itself could decrease the neuron/glia mitochondria ratio if the number of mitochondria per neuron decreases. Development of assays that allow a reliable and independent analysis of neuronal and glial mitochondria Ca 2+ -handling is essential to resolve this issue. So far, the only method that allows the isolation of pure neuronal versus glial mitochondria is to use primary cultures (Kristian et al. 2005) .
The present study is, to the best of our knowledge, the first to assess in situ HD mitochondrial respiratory function in intact (non-permeabilized) coverslip-attached neurons from transgenic mice. A recent study (Milakovic and Johnson 2005) (Trettel et al. 2000) . The immortalized cells were permeabilized with digitonin, an approach that allows the access of non-cell permeant reagents to the mitochondria inside the cells, permitting a comprehensive analysis of mitochondrial respiration but unavoidably leading to dialysis of soluble cytosolic components, and thus being bioenergetically equivalent to an isolated mitochondrial preparation. Milakovic and Johnson (2005) reported that mitochondrial respiration and ATP production were significantly impaired in STHdh 111/111 cells when compared with STHdh +/+ cells, however, neither significant differences were found in the activity of the mitochondrial respiratory complexes, nor in the total ATP cellular levels. The authors suggest that in intact cells, under resting conditions, mitochondria are likely not to function at maximal capacity and that only under conditions of neuronal stress would the mitochondrial impairment contribute to HD pathogenesis. Here we demonstrate that in intact striatal neurons, under resting conditions, mitochondria are indeed working at submaximal capacity. Furthermore, we show that under neuronal stress (NMDAR activation), when ATP is deriving solely from the mitochondria (pyruvate media), expression of full-length mutant Htt is associated with an increased vulnerability to Ca 2+ -deregulation. Our single-cell measurements suggest that this vulnerability is only restricted to a subset rather than to a uniform impairment of the neuronal population. This is consistent with the large in situ mitochondrial spare respiratory capacity of the neuronal population expressing mutant Htt. While no significant change in spare respiratory capacity argues against respiratory chain impairment, defects in ATP synthesis and/or export in HD neurons cannot be excluded.
Our in situ respiration data contrast with that of Milakovic and Johnson (2005) , first by the absence of significant differences in mitochondrial respiration, and second by much higher respiratory control ratios (RCR) in the present study. The fact that STHdh 111/111 cells express two copies of mutant Htt versus only one in Hdh 150/+ striatal neurons is a likely explanation for the first difference. Indeed, despite HD patients with two mutant alleles being very rare, evidence supports that homozygosity is associated with a more severe clinical course (Squitieri et al. 2003) , also, mouse studies show a clear gene dosage effect (Hickey and Chesselet 2003) . As both mutant and wild-type Htt associate with the mitochondria (Choo et al. 2004) , depletion of wild-type Htt because of homozygosity of the mutation may also play an important role (Cattaneo et al. 2001; Zhang et al. 2003) . Concerning differences in RCR values, which were £ 4 for the STHdh cell lines (both for state3/state4 or state3/uncoupled ratios, irrespective of the substrates) (Milakovic and Johnson 2005) and approximately 9-10 for striatal neurons in the present study, they may result both from differences in methodology and in the mitochondrial origin.
We could not find any published RCR data for brain mitochondria of HD mice. However, they are expected to be low based on available data from wild-type mouse brain isolated mitochondria [RCR = 1.6-2.0 (Lobao-Soares et al. 2005); 2.82 ± 0.13 (Xu et al. 2001) ; > 2 were used in experiments (Levy et al. 2003) ; and an exception of 7.5 ± 0.4 (Chavez et al. 1995) ]. Interestingly, a comparative study with rat mitochondria isolated from different tissues (Rossignol et al. 2000) reported the lowest RCR for the brain (2.6 ± 1.4), when compared with muscle, heart, liver and kidney. Significantly, mitochondria isolated from cultured rat neurons with a recently improved methodology presented RCRs of approximately 9-10 ( Kristian et al. 2005) . Moreover, our observation of mitochondria respiring at only 1/5 of maximal capacity in the basal state, is consistent with 500% spare respiratory capacity for in situ mitochondria in synaptosomes (Nicholls and Budd 2000) . Thus, it is likely that in situ neuronal mitochondria present more robust respiratory properties than commonly isolated brain mitochondria.
In summary, the present study shows an overall increase in the Ca 2+ -loading capacity of forebrain mitochondria from R6/2 and YAC128 HD mice. Because of limitations in the use of isolated non-synaptosomal preparations, it is presently unclear whether this represents a true mitochondrial resistance or changes in the neuronal/glial mitochondria ratio. Failure to observe such resistance in Hdh150 knock-in mice may be related to the slower progression of the disease in these mice and/or the concealment of a striatal selective effect in the forebrain mitochondria population. Studies of mitochondrial respiration in intact heterozygous Hdh150 striatal neurons reveal no significant defects in spare respiratory capacity, basal ATP synthesis, or uncoupling and do not support a uniform major bioenergetic defect in these neurons. Still, when the bioenergetic demand is strong, such as during NMDAR activation, a select population of HD striatal neurons may be unable to meet the increased ATP demand, perhaps because of defects in ATP synthesis/export. Additional studies, addressing in situ mitochondrial function in HD neurons and glial cells will be of importance to understand HD pathogenesis.
